India's Cipla posts 45% jump in Q4 profit on domestic drugs business boost

Cipla Ltd, India's third-largest drugmaker by sales, reported a 45.2% increase in fourth-quarter profit on Friday, driven by strength in its key domestic and North American drugs business.... | May 12, 2023

Related Keywords

Mumbai ,Maharashtra ,India ,United States ,Bengaluru ,Karnataka ,American ,Umang Vohra ,Sohini Goswami ,Rama Venkat ,Cipla ,Lupin Ltd ,North American ,Global Chief Executive Officer Umang Vohra ,Cipla Limited Stock Exchange ,News ,Information ,Press Release ,Drugmaker ,Y ,Eported ,Increase ,N ,Profit ,Riven ,Strength ,Its ,Key ,Domestic ,End ,North ,Rugs Cipla Ine059a01026 ,